In reference to reports, other EZH2 inhibitors like GSK343 and GSK236 are available to inhibit the tumor progression of various cancers as well, like glioblastoma [48], head and neck cancer [49] and breast cancer [50]. This evidence concerns the gene EZH2 and neoplasm.